Pharmacology

Modafinil has the potential for addiction

A group of neuroscientists and ethicists have recently published a paper warning about the perils of the use of pharmacological drugs for cognitive enhancement by healthy individuals. The paper can be found here: http://www.tandfonline.com/doi/abs/10.1080/ ...

Blog Post - Adm Mohamed - Apr 24 2012 - 4:03pm

Positive Phase 2 Study Met Primary End Point For Investigative Use Of Vyvanse In Adults With Binge Eating Disorder

Shire plc today announced positive top-line results from a Phase 2 study to evaluate the safety and efficacy of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules, (CII) in adults with binge eating disorder. Following discussions with the US Food and Drug A ...

Article - Newswire - Apr 27 2012 - 4:00am

Gabapentin Helps Marijuana Addicts Kick The Habit

Researchers have presented clinical evidence that the drug gabapentin, currently on the market to treat neuropathic pain and epilepsy, also helps people to quit smoking marijuana (cannabis). Unlike traditional addiction treatments, gabapentin targets stres ...

Article - News Staff - Apr 29 2012 - 12:30am

StarCap 1500® Co-Processed Starch Excipient Receives Pharmaceutical Precedence Of Use In The European Union

StarCap 1500® a co-processed excipient has recently gained precedence of use within the European Union (EU) in an approved drug product.  StarCap 1500 is comprised of both corn starch and pregelatinized starch and is designed specifically for use in pharm ...

Article - Newswire - Apr 30 2012 - 11:27am

Cranberry Capsule Shown To Cure Bladder Infection

Cranberries are known to help with  bladder and urinary tract infections and cranberry capsules do also, without known side effects, according to Dutch company Medical Brands, which has obtained a Class IIa Medical Device Status for its patented Cranberry ...

Article - Newswire - May 5 2012 - 3:30am

Pixuvri Approved For Adult Patients With Refractory Aggressive Non-Hodgkin B-Cell Lymphomas

Cell Therapeutics, Inc. ("CTI") today announced that it has received conditional marketing authorization from the European Commission ("EC") for Pixuvri (pixantrone) as monotherapy for the treatment of adult patients with multiply rela ...

Article - Newswire - May 11 2012 - 2:30am

JEVTANA Black Triangle Refused For Men With Advanced Prostate Cancer

The National Institute for Health and Clinical Excellence (NICE) has announced today that its decision not to approve JEVTANA[(R)Black Triangle Drug] (cabazitaxel) for use on the NHS will be upheld, following an appeal from Sanofi. This decision could eff ...

Article - Newswire - May 12 2012 - 11:43am

BOTOX Now For Migraine Headaches?

Allergan announced today that the National Institute for Health and Clinical Excellence (NICE) is recommending BOTOX(botulinum toxin type A) for the prophylaxis (prevention) of headache in adults with chronic migraine*, specifically in patients who have n ...

Article - Newswire - May 10 2012 - 8:19pm

New Innovations In Breast Cancer Pharmaceutical Market

As the second leading cause of death due to cancer in women, the pipeline for breast cancer therapeutics remains strong.  Although there are approximately 27 drugs on the market indicated for the treatment of breast cancer, there is currently an unmet nee ...

Article - Newswire - May 16 2012 - 11:30pm

Positive Phase 2 Clinical Data With Tivantinib In Hepatocellular Carcinoma

ArQule, Inc. and Daiichi Sankyo, Co., Ltd. (TSE 4568) today announced that an oral presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) will feature Phase 2 trial data with tivantinib as a single agent investigational sec ...

Article - Newswire - May 18 2012 - 5:30pm